
Icyiciro cya 3 kanseri y'ibihaha itari ntoya (NSCLC) itanga ibibazo byihariye, bisaba uburyo butandukanye bwo kuvura. Aka gatabo kasesenguye uburyo butandukanye bwo kuvura, bugaragaza imikorere yabyo, ingaruka zishobora guterwa, hamwe nuburyo bukwiranye nimpamvu z'abarwayi ku giti cyabo. Gusobanukirwa naya mahitamo ningirakamaro mu gufata ibyemezo byuzuye hamwe na oncologue wawe.
Icyiciro cya 3 NSCLC yashyizwe mu cyiciro cya IIIA na IIIB, byerekana urugero rwa kanseri ikwirakwira. Icyiciro cya IIIA kirimo kanseri yakwirakwiriye hafi ya lymph node, mugihe Stage IIIB ikubiyemo uruhare runini rwa lymph node kandi / cyangwa ikwirakwizwa mubikorwa byegeranye. Gutegura neza ukoresheje amashusho (CT scan, PET scan) na biopsies nibyingenzi muguhitamo igikwiye kuvura icyiciro cya 3 kitari gito kanseri yo kuvura kanseri y'ibihaha gahunda.
Kubaga birashobora kuba amahitamo yo gutoranya abarwayi bo mu cyiciro cya IIIA bafite uruhare ruto kandi bafite ubuzima bwiza muri rusange. Ibi bishobora kuba birimo lobectomy (kuvanaho ibihaha) cyangwa pneumonectomy (gukuramo ibihaha byose). Kubaga kubaga akenshi bikurikirwa no kuvura (chimiotherapie cyangwa imirasire) kugirango bigabanye ibyago byo kongera kubaho. Icyemezo cyo gukomeza kubagwa giterwa nibintu byinshi, harimo aho ikibyimba giherereye nubunini bwacyo, ubuzima bwumurwayi muri rusange, ndetse n’uruhare rwa lymph node. Shandong Baofa Ikigo Cyubushakashatsi Kanseri itanga ubumenyi bwuzuye bwo kubaga kanseri y'ibihaha.
Chimiotherapie, ukoresheje imiti ikomeye yica kanseri, nibisanzwe kuvura icyiciro cya 3 kitari gito kanseri yo kuvura kanseri y'ibihaha kuri Stage IIIA na IIIB NSCLC. Gahunda iratandukanye bitewe nibintu byihariye, kandi irashobora gushiramo imiti ishingiye kuri platine (cisplatine cyangwa karboplatine) ihujwe nibindi bikoresho nka pemetrexed cyangwa docetaxel. Chimiotherapie irashobora gutangwa mbere yo kubagwa (neoadjuvant) kugirango igabanye ikibyimba, nyuma yo kubagwa (adjuvant) kugirango ikureho kanseri zisigaye, cyangwa nkubuvuzi bwibanze. Ingaruka mbi zirasanzwe kandi zirimo gushiramo isesemi, umunaniro, no guta umusatsi; icyakora, akenshi birashobora gucungwa no kwitabwaho.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa wenyine cyangwa ifatanije na chimiotherapie. Imiti ivura imirasire irashobora gukoreshwa mbere yo kubagwa (neoadjuvant) kugirango igabanye ikibyimba, nyuma yo kubagwa (adjuvant) kugirango yibasire kanseri zose zisigaye, cyangwa nkubuvuzi bwibanze, cyane cyane kubarwayi badafite abakandida babaga. Ubuvuzi bwa stereotactique yumubiri (SBRT) nuburyo bwuzuye bwimirasire itanga urugero rwinshi rwimishwarara yibibyimba mugihe urinze ingirabuzimafatizo. Ubwoko bwihariye na dosiye yo kuvura imirasire biterwa nubuzima bwumuntu.
Ubuvuzi bugamije gukoresha imiti yibasira kanseri ya kanseri ishingiye ku ihinduka ry’imiterere yabyo. Guhindura genetike zimwe na zimwe (nka EGFR, ALK, ihinduka rya ROS1) birasanzwe muri NSCLC kandi birashobora guhanura uburyo bwo kuvura bwihariye. Niba ihinduka nkiryo ryamenyekanye, kuvura intego bishobora kuba ibuye ryimfuruka ya kuvura icyiciro cya 3 kitari gito kanseri yo kuvura kanseri y'ibihaha, birashoboka gutanga ibisubizo byiza hamwe ningaruka nke ugereranije na chimiotherapie gakondo. Oncologue wawe azakora ibizamini bya geneti kugirango amenye niba imiti igamije ikwiranye nawe.
Immunotherapie ikoresha imbaraga z'umubiri bwite wo kurwanya kanseri. Imiti igabanya ubukana, nka nivolumab cyangwa pembrolizumab, ikoreshwa mu guhagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Immunotherapy ikoreshwa kenshi hamwe na chimiotherapie kandi irashobora kuba amahitamo kubarwayi bafite imiterere yihariye ya genetike cyangwa abatitabira neza ubundi buvuzi. Ingaruka zo kuruhande zirashoboka kandi ziratandukanye bitewe n'imiti yihariye.
Ibyiza kuvura icyiciro cya 3 kitari gito kanseri yo kuvura kanseri y'ibihaha ingamba zishingiye ku bintu byinshi, harimo icyiciro cya kanseri, ubuzima bw’umurwayi muri rusange, ndetse no kuba hari ihinduka ry’imiterere yihariye. Itsinda ryibice byinshi byabaganga ba oncologiste, kubaga, hamwe nabavura imirasire bazafatanya gutegura gahunda yo kuvura yihariye. Gushyikirana kumugaragaro nubuvuzi bwawe nibyingenzi kugirango wumve amahitamo yawe kandi ufate ibyemezo byuzuye kubyerekeye ubuvuzi bwawe.
| Uburyo bwo kuvura | Inyungu Zishobora | Ingaruka Zishobora Kuruhande |
|---|---|---|
| Kubaga | Kurandura ibibyimba byuzuye | Kubabara, kwandura, ibibazo byubuhumekero |
| Chimoterapi | Yica selile kanseri mumubiri | Isesemi, kuruka, umunaniro, guta umusatsi |
| Ubuvuzi | Intego yibasira kanseri ya kanseri | Kurakara uruhu, umunaniro, kumira ingorane |
| Ubuvuzi bugamije | By'umwihariko yibasira kanseri ya kanseri ihindagurika | Rash, impiswi, umunaniro |
| Immunotherapy | Bitera ubudahangarwa bw'umubiri kurwanya kanseri | Umunaniro, guhubuka, impiswi, gutwika ibihaha |
Aya makuru agamije intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza abashinzwe ubuzima kugirango basuzume kandi bavure indwara iyo ari yo yose.
Inshingano: Aya makuru agenewe ubumenyi rusange nintego zamakuru gusa, kandi ntabwo bigize inama zubuvuzi. Ni ngombwa kugisha inama inzobere mu by'ubuzima zibishoboye kubibazo byose byubuzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa kwivuza. Ibisobanuro byatanzwe hano ntibigomba gufatwa nkibisimbuza inama zubuvuzi zumwuga, gusuzuma, cyangwa kwivuza.